Top Navigation

 

Press Release

 

Azure Biosystems Launches a next generation laser scanner system with Visible and NIR fluorescent, Chemiluminescent and Phosphor Imaging capability.

Dublin, Calif. – August 15, 2017 – Azure Biosystems Inc. is pleased to announce the Sapphire™ Biomolecular Imager, a novel laser scanner whose patent pending design uniquely offers fluorescent imaging in the Near IR (NIR) and Visible Wavelengths (RGB), true chemiluminescent imaging as well as scanning of storage phosphor screens. The application flexibility, sensitivity, and resolution down to 10 microns, makes this an ideal imaging system for proteomics research labs.

The Sapphire Biomolecular Imager achieves high performance and application flexibility by combining up to 4 solid-state laser diodes and three different detection methods: Photo multiplier tubes (PMTs), Avalanche photodiodes (APDs) and a cooled CCD camera. Previously, labs that needed the ultimate sensitivity for chemiluminescent, phosphor imaging and fluorescent imaging, would have to buy two or three separate, high priced instruments. Combining powerful performance into one system gives researchers a choice they have never had before, fully streamlining their workflow.

At the core of the Sapphire Biomolecular Imager is its unique easy to use capture software that walks the user through the imaging set up process, enabling scientists to design personalised workflows allowing for rapid, reproducible quantifications.

“The Sapphire Biomolecular Imager demonstrates Azure Biosystems’s passion for innovating products that reflect real customer needs,” said Lisa Isailovic, Vice-President of Marketing. “This multimodal system is the first alternative to existing laser based NIR and phosphor imaging systems, plus it offers chemiluminescent imaging, a standard in proteomics research.”

Azure Biosystems is a technical leader in the field of digital imaging for life sciences, who introduced the cSeries digital imaging system in 2013, and now has thousands of cSeries customers globally.

The Sapphire Biomolecular Imager will begin shipping in October 2017.

 

About Azure Biosystems

Azure Biosystems Inc. is an innovative life science platform company that designs, develops and markets state-of-the-art instruments, including the Ao absorbance microplate reader and the cSeries imaging platforms. Azure Biosystem’s experienced team has developed 2nd and 3rd generation imaging systems for the life science market, thus applying their technical and market knowledge in creating innovative industry standard setting platforms.

For additional information, please see https://www.azurebiosystems.com.

 

Contact

Lisa Isailovic
lisa.isailovic@azurebiosystems.com
(925) 307-7127